Involved site radiation therapy for the treatment of early-stage Hodgkin lymphoma in adolescents and young adults.

Abstract

Radiation therapy technology has permitted the development of new treatment planning techniques. Involved field, involved node, and involved site radiotherapy fields are discussed and compared. Indications for and implications of combined modality therapy are examined, particularly as pertinent to the adolescent and young adult population.